輸入代號或公司名稱後按 Enter
4147

中裕

+1.20 (+2.01%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
60.80547成交張數本益比4.39股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入 · 未來期間為分析師共識預估(2026-09-09)

營業收入2025611年增 +0.2%
毛利率202542.4%最新一期
營業利益率2025-31.8%最新一期
每股盈餘2025-0.61
會計項目走勢20162017201820192020202120222023202420252026 預估 3 家2027 預估 2 家
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計108.2%67.4%55.5%79.7%61.7%54.2%65.4%57.6%
營業毛利(毛損)100.0%100.0%-8.2%32.6%44.5%20.3%38.3%45.8%34.6%42.4%49.0%52.5%
營業毛利(毛損)淨額100.0%100.0%-8.2%32.6%44.5%20.3%38.3%45.8%34.6%42.4%
推銷費用0.0%0.0%2.3%15.3%4.3%8.6%2.5%3.4%
管理費用1848.0%508.7%17.7%6.3%6.0%11.3%8.9%11.2%9.8%8.4%
研究發展費用13324.1%6054.3%182.7%81.7%54.6%111.4%59.2%59.8%63.6%62.5%
營業費用合計15172.2%6563.0%200.4%88.0%62.8%137.9%72.4%79.6%76.0%74.3%
營業利益(損失)-15072.2%-6463.0%-133.1%-55.4%-18.4%-117.6%-34.1%-33.8%-41.3%-31.8%-28.5%-24.7%
利息收入1.2%1.0%0.8%1.7%5.6%4.7%
其他收入1433.6%479.1%8.4%2.8%0.7%1.0%0.5%1.1%0.9%0.8%
其他利益及損失淨額56.6%-234.2%-8.8%-29.5%-8.3%3.6%-13.3%-5.6%3.8%0.6%
財務成本淨額0.1%0.6%1.8%1.8%3.0%2.1%1.8%
營業外收入及支出合計1490.2%244.9%-0.4%-26.8%-7.0%3.7%-13.8%-5.8%8.3%4.4%
稅前淨利(淨損)-13582.0%-6218.0%-133.5%-82.1%-25.4%-113.9%-47.8%-39.6%-33.1%-27.4%
繼續營業單位本期淨利(淨損)-13582.0%-6218.0%-133.5%-82.1%-25.4%-113.9%-47.8%-39.6%-33.1%-27.4%
本期淨利(淨損)-13582.0%-6218.0%-133.5%-82.1%-25.4%-113.9%-47.8%-39.6%-33.1%-27.4%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益0.3%-0.0%0.0%-3.7%1.2%0.1%-3.1%-1.0%
不重分類至損益之項目:-0.0%0.0%-3.7%1.2%0.1%-3.1%-1.0%
國外營運機構財務報表換算之兌換差額-53.5%-66.1%1.1%-0.4%-0.8%-0.7%2.4%-0.1%2.0%-1.4%
透過其他綜合損益按公允價值衡量之債務工具投資未實現評價損益-0.1%0.0%
後續可能重分類至損益之項目:-0.4%-0.8%-0.7%2.4%-0.1%1.8%-1.4%
其他綜合損益(淨額)-53.5%578.4%1.4%-0.4%-0.8%-4.4%3.6%0.0%-1.3%-2.5%
本期綜合損益總額-13635.5%-5639.7%-132.1%-82.5%-26.2%-118.3%-44.3%-39.6%-34.4%-29.9%
母公司業主(淨利∕損)-13582.0%-6218.0%-133.5%-82.1%-25.4%-113.9%-47.8%-39.6%-33.1%-27.4%-25.5%-21.4%
母公司業主(綜合損益)-13635.5%-5639.7%-132.1%-82.5%-26.2%-118.3%-44.3%-39.6%-34.4%-29.9%
基本每股盈餘-54.9%-24.9%-0.5%-0.3%-0.1%-0.5%-0.2%-0.2%-0.1%-0.1%-0.1%-0.1%
繼續營業單位淨利(淨損)-0.1%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%
稀釋每股盈餘-0.3%-0.1%-0.5%-0.2%-0.2%-0.1%-0.1%
銷貨成本38.9%
其他營業成本40.8%
其他收益及費損淨額0.0%0.0%75.5%0.0%
其他收益0.0%0.0%75.5%
備供出售金融資產未實現評價損益644.5%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。最右邊的預估欄是分析師共識預估(2026-09-09),營收、營業利益、母公司淨利、每股盈餘直接取共識平均,毛利由共識營收乘上共識毛利率推算,不是公司財測。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。